Twitxy Saved

Andrew Waters

@AndrewMWaters

Assistant Professor at University of Cincinnati | Surgical Oncology | Cancer Biology
med.uc.edu/depart/cancer-…
views are my own
Cincinnati, OH Joined January 2015
774 Following 674 Followers 734 Posts

Latest posts 5

Pinned post

Andrew Waters @AndrewMWaters
Excited to share my first last-author research paper in @CR_AACR where we comprehensively identify and validate resistance mechanisms to KRAS inhibitors in #PancreaticCancer.

This work was led by a fantastic medical resident @SzuAunLongMD, and two phenomenal grad students Haley Todd and @grace_goodhart. @SyedAAhmad5 @ambermamparo @bryant_kl @G_AaronHobbs @UCincySurg @Julien__Dilly @cjder23

Take-home messages:
1. KRAS Q61H-mutant PDAC is genetically and pharmacologically less dependent on KRAS for survival. We think this is due to biochemical idiosyncrasies that create an increased dependence on WT RAS isoforms. This creates a susceptibility to combined EGFR inhibition in a KRAS Q61H-mutant setting in PDAC models.

2. Additional validated hits include PI3K alpha and gamma, YAP, CK2 (formerly known as casein kinase 2).

3. We also generated KRASi-resistant PDAC cell lines that underwent an EMT, had low ERK MAPK signaling (yet remained dependent on ERK MAPK signaling), and we determine that after a 30 day compound removal, resistance was largely reversible.

Support from @theNCI @AmericanCancer @PanCAN among others.

aacrjournals.org/cancerres/arti…
aacrjournals.org CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer A comprehensive assessment of genetic modulators of KRAS inhibitor sensitivity identifies combination approaches to increase the efficacy of KRAS inhibitors and demonstrates the limited response of...
2 replies 9 reposts 49 likes 5.1K views View on X
Andrew Waters @AndrewMWaters
Credit here goes to the scientists in the lab and support from the @uofcincycancer ! @grace_goodhart @SzuAunLongMD
PanCAN Verified account @PanCAN Sep 17
We are pleased to announce @AndrewWaters, PhD, from @UC_Health, as a 2026 PanCAN grant recipient, made possible by generous support from PanCAN donors. 🔬

Dr. Waters will lead a research project titled “Determining the role of KSR in mediating resistance to KRAS inhibition in PDAC.” This grant is in memory of Terry Newendrop.

Read more about Dr. Waters’s project at 🔗 pcan.at/bs58394r.
View quoted post on X
0 replies 0 reposts 11 likes 424 views View on X